Concepts (327)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 15 | 2024 | 937 | 3.080 |
Why?
|
| Muscle Strength | 12 | 2024 | 75 | 2.370 |
Why?
|
| High-Intensity Interval Training | 3 | 2022 | 3 | 1.680 |
Why?
|
| Spatial Navigation | 3 | 2022 | 27 | 1.590 |
Why?
|
| Dietary Supplements | 12 | 2024 | 472 | 1.570 |
Why?
|
| Fasting | 5 | 2022 | 297 | 1.550 |
Why?
|
| Creatine | 3 | 2018 | 41 | 1.390 |
Why?
|
| Resistance Training | 7 | 2022 | 32 | 1.250 |
Why?
|
| Exercise | 11 | 2022 | 810 | 1.080 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 678 | 1.040 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2024 | 114 | 0.930 |
Why?
|
| Synbiotics | 1 | 2024 | 7 | 0.930 |
Why?
|
| Hand Strength | 1 | 2024 | 42 | 0.910 |
Why?
|
| Sarcopenia | 1 | 2024 | 39 | 0.880 |
Why?
|
| Conjugation, Genetic | 1 | 2023 | 9 | 0.850 |
Why?
|
| Body Composition | 9 | 2024 | 513 | 0.850 |
Why?
|
| Type IV Secretion Systems | 1 | 2023 | 7 | 0.850 |
Why?
|
| DNA Replication | 1 | 2024 | 343 | 0.820 |
Why?
|
| Obesity | 8 | 2022 | 2227 | 0.810 |
Why?
|
| DNA Damage | 1 | 2024 | 507 | 0.760 |
Why?
|
| Physical Conditioning, Animal | 2 | 2020 | 91 | 0.720 |
Why?
|
| Energy Intake | 2 | 2020 | 489 | 0.690 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2019 | 15 | 0.680 |
Why?
|
| Adipose Tissue, White | 1 | 2020 | 79 | 0.670 |
Why?
|
| Ghrelin | 1 | 2019 | 51 | 0.660 |
Why?
|
| Recovery of Function | 4 | 2018 | 438 | 0.660 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1068 | 0.650 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 207 | 0.650 |
Why?
|
| Transcription, Genetic | 1 | 2024 | 1695 | 0.650 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 330 | 0.620 |
Why?
|
| Hypothalamus | 1 | 2020 | 216 | 0.620 |
Why?
|
| Whey Proteins | 1 | 2018 | 6 | 0.620 |
Why?
|
| Isometric Contraction | 1 | 2018 | 22 | 0.610 |
Why?
|
| Diet Fads | 1 | 2018 | 1 | 0.610 |
Why?
|
| Myalgia | 1 | 2018 | 11 | 0.610 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2015 | 63 | 0.600 |
Why?
|
| Muscle Development | 1 | 2018 | 71 | 0.590 |
Why?
|
| Microbiota | 1 | 2022 | 388 | 0.580 |
Why?
|
| Lipoproteins, LDL | 1 | 2018 | 116 | 0.580 |
Why?
|
| Muscular Diseases | 1 | 2018 | 102 | 0.570 |
Why?
|
| Maze Learning | 4 | 2022 | 127 | 0.550 |
Why?
|
| Oxidative Stress | 4 | 2018 | 796 | 0.540 |
Why?
|
| Physical Fitness | 2 | 2013 | 91 | 0.530 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 173 | 0.530 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2528 | 0.530 |
Why?
|
| Diet | 7 | 2022 | 1126 | 0.510 |
Why?
|
| Regeneration | 1 | 2018 | 202 | 0.510 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 130 | 0.500 |
Why?
|
| Energy Metabolism | 3 | 2019 | 769 | 0.490 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 74 | 0.480 |
Why?
|
| Life Style | 2 | 2017 | 403 | 0.480 |
Why?
|
| Insulin Resistance | 2 | 2018 | 638 | 0.480 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 766 | 0.480 |
Why?
|
| Software | 1 | 2019 | 677 | 0.470 |
Why?
|
| Dietary Carbohydrates | 4 | 2022 | 118 | 0.450 |
Why?
|
| Weight Loss | 5 | 2022 | 478 | 0.450 |
Why?
|
| Genotype | 1 | 2019 | 2541 | 0.440 |
Why?
|
| Physiology | 2 | 2023 | 14 | 0.430 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 1863 | 0.420 |
Why?
|
| Male | 31 | 2024 | 60117 | 0.400 |
Why?
|
| Aging | 4 | 2013 | 1174 | 0.390 |
Why?
|
| Weight Gain | 3 | 2020 | 401 | 0.380 |
Why?
|
| Biomarkers | 8 | 2022 | 2945 | 0.360 |
Why?
|
| Carnosine | 1 | 2010 | 1 | 0.350 |
Why?
|
| Inflammation | 9 | 2022 | 1402 | 0.350 |
Why?
|
| MicroRNAs | 1 | 2017 | 827 | 0.350 |
Why?
|
| Double-Blind Method | 7 | 2024 | 1589 | 0.350 |
Why?
|
| beta-Alanine | 1 | 2010 | 8 | 0.350 |
Why?
|
| Humans | 45 | 2024 | 123213 | 0.330 |
Why?
|
| Overweight | 2 | 2022 | 358 | 0.330 |
Why?
|
| Australia | 3 | 2024 | 140 | 0.330 |
Why?
|
| Female | 25 | 2024 | 65516 | 0.320 |
Why?
|
| Blood Glucose | 4 | 2022 | 1118 | 0.310 |
Why?
|
| Muscle Proteins | 3 | 2018 | 416 | 0.310 |
Why?
|
| Adult | 24 | 2022 | 29091 | 0.300 |
Why?
|
| Inflammation Mediators | 4 | 2010 | 233 | 0.300 |
Why?
|
| Neurogenesis | 2 | 2020 | 196 | 0.300 |
Why?
|
| Curriculum | 2 | 2023 | 719 | 0.290 |
Why?
|
| Animals | 13 | 2022 | 33761 | 0.290 |
Why?
|
| Sex Characteristics | 2 | 2020 | 313 | 0.280 |
Why?
|
| Young Adult | 14 | 2022 | 8886 | 0.280 |
Why?
|
| Middle Aged | 19 | 2024 | 26009 | 0.270 |
Why?
|
| Physical Endurance | 3 | 2015 | 46 | 0.260 |
Why?
|
| Adiposity | 2 | 2018 | 191 | 0.260 |
Why?
|
| Adaptation, Physiological | 2 | 2020 | 260 | 0.260 |
Why?
|
| Boswellia | 2 | 2017 | 2 | 0.250 |
Why?
|
| Walking Speed | 1 | 2024 | 15 | 0.230 |
Why?
|
| Aged | 12 | 2024 | 19089 | 0.230 |
Why?
|
| Quality of Life | 1 | 2013 | 1932 | 0.230 |
Why?
|
| Golf | 1 | 2023 | 4 | 0.220 |
Why?
|
| Genome, Viral | 1 | 2024 | 170 | 0.220 |
Why?
|
| Genomic Instability | 1 | 2024 | 229 | 0.210 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2023 | 42 | 0.210 |
Why?
|
| Sports | 1 | 2023 | 59 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 280 | 0.210 |
Why?
|
| Range of Motion, Articular | 3 | 2018 | 73 | 0.210 |
Why?
|
| Mutation | 5 | 2024 | 5773 | 0.200 |
Why?
|
| Spatial Memory | 1 | 2022 | 37 | 0.200 |
Why?
|
| Goals | 2 | 2019 | 130 | 0.190 |
Why?
|
| Running | 3 | 2018 | 37 | 0.190 |
Why?
|
| Plasmids | 1 | 2023 | 509 | 0.190 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 156 | 0.190 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2017 | 715 | 0.190 |
Why?
|
| RNA, Viral | 1 | 2024 | 541 | 0.190 |
Why?
|
| Exercise Test | 3 | 2018 | 249 | 0.190 |
Why?
|
| Nutrition Assessment | 1 | 2022 | 133 | 0.180 |
Why?
|
| Gallbladder Neoplasms | 1 | 2020 | 13 | 0.180 |
Why?
|
| Physical Conditioning, Human | 1 | 2020 | 2 | 0.180 |
Why?
|
| Phytotherapy | 2 | 2013 | 50 | 0.180 |
Why?
|
| Virus Replication | 1 | 2024 | 603 | 0.180 |
Why?
|
| RNA, Messenger | 3 | 2020 | 2815 | 0.180 |
Why?
|
| Mice, Obese | 1 | 2020 | 78 | 0.180 |
Why?
|
| Mice | 4 | 2022 | 17496 | 0.170 |
Why?
|
| Soy Milk | 2 | 2010 | 3 | 0.170 |
Why?
|
| Torque | 2 | 2018 | 10 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4348 | 0.170 |
Why?
|
| Creatine Kinase | 2 | 2018 | 54 | 0.170 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 97 | 0.170 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 105 | 0.170 |
Why?
|
| Dietary Fats | 2 | 2020 | 296 | 0.160 |
Why?
|
| Leptin | 1 | 2020 | 211 | 0.160 |
Why?
|
| Diet, High-Protein | 1 | 2018 | 5 | 0.160 |
Why?
|
| Ankle Injuries | 1 | 2018 | 33 | 0.160 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 142 | 0.150 |
Why?
|
| Cytoprotection | 1 | 2018 | 39 | 0.150 |
Why?
|
| Plant Extracts | 2 | 2017 | 120 | 0.150 |
Why?
|
| Bupivacaine | 1 | 2018 | 21 | 0.150 |
Why?
|
| Rectal Neoplasms | 1 | 2019 | 76 | 0.150 |
Why?
|
| Diet, Western | 1 | 2018 | 17 | 0.150 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 82 | 0.150 |
Why?
|
| Military Personnel | 1 | 2020 | 209 | 0.150 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 75 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 274 | 0.150 |
Why?
|
| Cognition | 1 | 2022 | 735 | 0.150 |
Why?
|
| Hippocampus | 2 | 2020 | 820 | 0.140 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 879 | 0.140 |
Why?
|
| Eicosanoids | 1 | 2017 | 13 | 0.140 |
Why?
|
| Glucose Intolerance | 1 | 2018 | 75 | 0.140 |
Why?
|
| DNA Repair | 1 | 2020 | 581 | 0.140 |
Why?
|
| Patient Compliance | 2 | 2018 | 467 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4276 | 0.140 |
Why?
|
| Random Allocation | 1 | 2018 | 427 | 0.140 |
Why?
|
| Curcumin | 1 | 2017 | 41 | 0.140 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 245 | 0.140 |
Why?
|
| Sarcoma | 1 | 2019 | 195 | 0.140 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 240 | 0.140 |
Why?
|
| Insulin | 2 | 2019 | 1200 | 0.140 |
Why?
|
| Perception | 1 | 2018 | 221 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 606 | 0.130 |
Why?
|
| Kidney | 1 | 2023 | 1339 | 0.130 |
Why?
|
| Memory | 1 | 2019 | 361 | 0.130 |
Why?
|
| Microsatellite Instability | 3 | 2020 | 36 | 0.130 |
Why?
|
| Health Status | 2 | 2018 | 374 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6373 | 0.130 |
Why?
|
| Postmenopause | 3 | 2010 | 125 | 0.120 |
Why?
|
| Biomarkers, Tumor | 2 | 2020 | 1430 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1215 | 0.120 |
Why?
|
| Glucose | 1 | 2019 | 872 | 0.120 |
Why?
|
| Dystrophin | 1 | 2014 | 37 | 0.120 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 31 | 0.120 |
Why?
|
| Alleles | 1 | 2019 | 1603 | 0.120 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 433 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1240 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3379 | 0.110 |
Why?
|
| Narration | 1 | 2013 | 29 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 287 | 0.110 |
Why?
|
| Curcuma | 1 | 2013 | 1 | 0.110 |
Why?
|
| Leucine | 1 | 2015 | 309 | 0.110 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2014 | 75 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 560 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2015 | 340 | 0.110 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 169 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2019 | 1480 | 0.100 |
Why?
|
| Neoplasm Proteins | 2 | 2020 | 669 | 0.100 |
Why?
|
| Age Factors | 4 | 2020 | 2802 | 0.100 |
Why?
|
| Milk | 2 | 2010 | 118 | 0.100 |
Why?
|
| Universities | 2 | 2023 | 126 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2014 | 667 | 0.100 |
Why?
|
| Racquet Sports | 1 | 2012 | 1 | 0.100 |
Why?
|
| Sirolimus | 1 | 2014 | 220 | 0.100 |
Why?
|
| Peptide Hydrolases | 2 | 2011 | 141 | 0.100 |
Why?
|
| Athletic Performance | 1 | 2012 | 9 | 0.100 |
Why?
|
| Muscle Contraction | 2 | 2010 | 186 | 0.100 |
Why?
|
| Mutation Rate | 2 | 2024 | 66 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12134 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1530 | 0.100 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2011 | 5 | 0.100 |
Why?
|
| Motor Skills | 1 | 2012 | 84 | 0.100 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 11 | 0.100 |
Why?
|
| Fish Oils | 1 | 2012 | 82 | 0.090 |
Why?
|
| Docosahexaenoic Acids | 1 | 2012 | 66 | 0.090 |
Why?
|
| Food, Formulated | 1 | 2011 | 52 | 0.090 |
Why?
|
| Milk Proteins | 1 | 2011 | 91 | 0.090 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2011 | 25 | 0.090 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2012 | 79 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3045 | 0.090 |
Why?
|
| Brain | 1 | 2022 | 2962 | 0.090 |
Why?
|
| Interleukin-6 | 4 | 2014 | 393 | 0.090 |
Why?
|
| NF-kappa B | 2 | 2010 | 455 | 0.090 |
Why?
|
| Neurons | 1 | 2020 | 1933 | 0.090 |
Why?
|
| Mitochondria | 1 | 2014 | 677 | 0.080 |
Why?
|
| Rats, Long-Evans | 2 | 2020 | 103 | 0.080 |
Why?
|
| Plant Preparations | 1 | 2009 | 18 | 0.080 |
Why?
|
| Adolescent | 8 | 2020 | 19124 | 0.080 |
Why?
|
| Enzymes | 1 | 2009 | 51 | 0.080 |
Why?
|
| Dietary Proteins | 3 | 2020 | 242 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 425 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 4 | 2010 | 158 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 368 | 0.080 |
Why?
|
| Sex Factors | 3 | 2018 | 1259 | 0.080 |
Why?
|
| Ephedra | 1 | 2008 | 2 | 0.080 |
Why?
|
| Health Promotion | 1 | 2011 | 389 | 0.070 |
Why?
|
| Genomics | 3 | 2020 | 1478 | 0.070 |
Why?
|
| Caffeine | 1 | 2008 | 71 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 522 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 125 | 0.070 |
Why?
|
| Glutathione Peroxidase | 3 | 2013 | 32 | 0.070 |
Why?
|
| Superoxide Dismutase | 3 | 2010 | 140 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2014 | 4493 | 0.060 |
Why?
|
| Time Factors | 4 | 2018 | 6217 | 0.050 |
Why?
|
| Body Weight | 2 | 2022 | 1001 | 0.050 |
Why?
|
| Genome, Human | 2 | 2020 | 1267 | 0.050 |
Why?
|
| Athletes | 1 | 2023 | 61 | 0.050 |
Why?
|
| Basal Metabolism | 2 | 2014 | 93 | 0.050 |
Why?
|
| Appetite | 1 | 2022 | 34 | 0.050 |
Why?
|
| Hunger | 1 | 2022 | 50 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2022 | 84 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 200 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 375 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2023 | 304 | 0.050 |
Why?
|
| Hypoxia | 1 | 2022 | 247 | 0.050 |
Why?
|
| Recommended Dietary Allowances | 1 | 2020 | 23 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2024 | 672 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2014 | 310 | 0.040 |
Why?
|
| Interleukin-1beta | 2 | 2012 | 159 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2019 | 16 | 0.040 |
Why?
|
| Learning | 1 | 2023 | 361 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 307 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 2020 | 176 | 0.040 |
Why?
|
| Consensus | 1 | 2023 | 609 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2019 | 27 | 0.040 |
Why?
|
| Habits | 1 | 2019 | 26 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 2010 | 235 | 0.040 |
Why?
|
| Smad4 Protein | 1 | 2019 | 55 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 74 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 557 | 0.040 |
Why?
|
| Interleukins | 2 | 2009 | 118 | 0.040 |
Why?
|
| Homeostasis | 1 | 2022 | 682 | 0.040 |
Why?
|
| United Kingdom | 1 | 2018 | 191 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 567 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 467 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 164 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2018 | 6033 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2020 | 991 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2014 | 1541 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 501 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1088 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1213 | 0.030 |
Why?
|
| Pain | 1 | 2018 | 470 | 0.030 |
Why?
|
| Citrate (si)-Synthase | 1 | 2014 | 19 | 0.030 |
Why?
|
| Muscle Stretching Exercises | 1 | 2014 | 2 | 0.030 |
Why?
|
| Ergometry | 1 | 2014 | 5 | 0.030 |
Why?
|
| Muscle Fatigue | 1 | 2014 | 7 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 715 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 2014 | 44 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1422 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2014 | 146 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2014 | 215 | 0.030 |
Why?
|
| Diaphragm | 1 | 2014 | 97 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 26 | 0.030 |
Why?
|
| Affect | 1 | 2014 | 155 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2014 | 78 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1794 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3654 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 1870 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1388 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2013 | 271 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2011 | 45 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2842 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 75 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 66 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2011 | 67 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 428 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 490 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2011 | 95 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 424 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 338 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 406 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 666 | 0.020 |
Why?
|
| Movement | 1 | 2012 | 167 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 211 | 0.020 |
Why?
|
| Cattle | 1 | 2011 | 559 | 0.020 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2010 | 13 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2011 | 284 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2011 | 225 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 4705 | 0.020 |
Why?
|
| Basophils | 1 | 2009 | 11 | 0.020 |
Why?
|
| Dinoprost | 1 | 2009 | 28 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2010 | 53 | 0.020 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2009 | 6 | 0.020 |
Why?
|
| Quadriceps Muscle | 1 | 2009 | 12 | 0.020 |
Why?
|
| Texas | 1 | 2018 | 3558 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1010 | 0.020 |
Why?
|
| Soybean Proteins | 1 | 2009 | 18 | 0.020 |
Why?
|
| Calcium | 1 | 2014 | 1096 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 4507 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2009 | 76 | 0.020 |
Why?
|
| Isoflavones | 1 | 2009 | 44 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 449 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 247 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2009 | 169 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2009 | 115 | 0.020 |
Why?
|
| Eosinophils | 1 | 2009 | 121 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 587 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 352 | 0.020 |
Why?
|
| Weight Lifting | 1 | 2008 | 6 | 0.020 |
Why?
|
| Physical Education and Training | 1 | 2008 | 20 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1415 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 671 | 0.020 |
Why?
|
| Neutrophils | 1 | 2009 | 372 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1584 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1781 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 10015 | 0.010 |
Why?
|
| United States | 1 | 2019 | 10633 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 1285 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5047 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1661 | 0.010 |
Why?
|